Our core target EGFR had significant positive correlation results in Thymoma, Kidney Chromophobe, Diffuse Large B-Cell Lymphoma, Brain Lower Grade Glioma, and Skin Cutaneous Melanoma. This evidence concerns the gene EGFR and central nervous system cancer.